Literature DB >> 10197671

Is mediastinitis a preventable complication? A 10-year review.

R J Baskett1, C E MacDougall, D B Ross.   

Abstract

BACKGROUND: The incidence of mediastinitis after cardiac surgical intervention is reported to be between 0.15% and 5% and is a major cause of postoperative morbidity. A number of risk factors have been identified, most of which are not modifiable. It is our contention that this complication can be reduced to a minimum by the consistent application of good operative technique and postoperative management.
METHODS: We reviewed the records of all 9,771 patients who underwent cardiac surgical procedures between 1987 and 1997. All operations were performed using a common skin preparation, draping, and antibiotic prophylaxis. Cases of mediastinitis were defined according to Centers for Disease Control and Prevention criteria and were identified from three sources: medical records database, hospital infection control, and the Society of Thoracic Surgeons database. Risk factors were assessed using chi2 and Fisher's exact tests.
RESULTS: Of 24 patients identified as having deep sternal wound infection (incidence, 0.25%), 2 died (mortality rate, 8.3%), 18 required reoperation (75%), and only 4 needed pectoral muscle flaps. Statistical analysis revealed only the presence of chronic obstructive pulmonary disease as a significant risk factor (p < 0.01). Other factors, including diabetes, renal failure, smoking, sex, age, reoperation, morbid obesity, and steroid use, were not significant. The use of internal mammary arteries (single or bilateral) was not associated with mediastinitis. Postoperative complications, including prolonged ventilation, inotropic support, and the need for blood products, were not significant risk factors. The patients who developed mediastinitis were more likely to be readmitted to the hospital (p < 0.005) and more likely to require reoperation (p < 0.005).
CONCLUSIONS: In a large patient series we found a low incidence of mediastinitis (0.25%) and an even lower incidence of required reoperation (0.19%). Except for the use of bone wax and the use of bilateral mammary arteries in diabetic patients, none of the previously identified risk factors are modifiable. We believe that with strict adherence to perioperative aseptic technique, attention to hemostasis, and precise sternal closure, a very low incidence of mediastinitis can be achieved.

Entities:  

Mesh:

Year:  1999        PMID: 10197671     DOI: 10.1016/s0003-4975(98)01195-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  23 in total

1.  The management of deep sternal wound infections using vacuum assisted closure (V.A.C.) therapy.

Authors:  Tatjana Fleck; Ronny Gustafsson; Keith Harding; Richard Ingemansson; Mitchell D Lirtzman; Herbert L Meites; Reinhard Moidl; Patricia Price; Andrew Ritchie; Jorge Salazar; Johan Sjögren; David H Song; Bauer E Sumpio; Boulos Toursarkissian; Ferdinand Waldenberger; Walter Wetzel-Roth
Journal:  Int Wound J       Date:  2006-12       Impact factor: 3.315

2.  Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis.

Authors:  O Friberg; R Svedjeholm; J Källman; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

3.  Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction.

Authors:  T Buratti; G Ricevuti; C Pechlaner; M Joannidis; F J Wiedermann; D Gritti; M Herold; C J Wiedermann
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

4.  Corpus sterni reinforcement improves the stability of primary sternal closure in high-risk patients.

Authors:  Erkan Iriz; Dilek Erer; Pinar Koksal; Mehmet Emin Ozdogan; Velit Halit; Volkan Sinci; Levent Gokgoz; Ali Yener
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

5.  Ventral hernia repairs in the oldest-old: high-risk regardless of approach.

Authors:  Konstantinos Spaniolas; Thadeus L Trus; Gina L Adrales
Journal:  Surg Endosc       Date:  2013-11-21       Impact factor: 4.584

6.  Mitral valve replacement via right thoracotomy approach for prevention of mediastinitis in a female patient with long-term uncontrolled diabetes mellitus: a case report.

Authors:  Naoto Fukunaga; Takashi Hashimoto; Yasuhisa Ozu; Shigeru Komori; Yu Shomura; Hiroshi Fujiwara; Michihiro Nasu; Yukikatsu Okada
Journal:  J Cardiothorac Surg       Date:  2010-05-17       Impact factor: 1.637

7.  Vacuum-assisted closure and bilateral pectoralis muscle flaps for different stages of mediastinitis after cardiac surgery.

Authors:  Zeynep Eyileten; Ahmet Ruchan Akar; Sadik Eryilmaz; Mustafa Sirlak; Levent Yazicioglu; Serkan Durdu; Adnan Uysalel; Umit Ozyurda
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

8.  Evaluation of risk factors for hospital mortality and current treatment for poststernotomy mediastinitis.

Authors:  Akimasa Morisaki; Mitsuharu Hosono; Yasuyuki Sasaki; Hidekazu Hirai; Masanori Sakaguchi; Atsushi Nakahira; Hiroyuki Seo; Shigefumi Suehiro; Toshihiko Shibata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-04-12

9.  Ostene, a new alkylene oxide copolymer bone hemostatic material, does not inhibit bone healing.

Authors:  Clara E Magyar; Tara L Aghaloo; Elisa Atti; Sotirios Tetradis
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

Review 10.  V.A.C. Therapy in the management of paediatric wounds: clinical review and experience.

Authors:  Mona Baharestani; Ibrahim Amjad; Kim Bookout; Tatjana Fleck; Allen Gabriel; David Kaufman; Shannon Stone McCord; Donald C Moores; Oluyinka O Olutoye; Jorge D Salazar; David H Song; Steven Teich; Subhas Gupta
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.